Gene: NPAS4
Official Full Name: neuronal PAS domain protein 4provided by HGNC
Gene Summary: NXF is a member of the basic helix-loop-helix-PER (MIM 602260)-ARNT (MIM 126110)-SIM (see SIM2; MIM 600892) (bHLH-PAS) class of transcriptional regulators, which are involved in a wide range of physiologic and developmental events (Ooe et al., 2004 [PubMed 14701734]).[supplied by OMIM, Mar 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO20883 | NPAS4 Knockout cell line (HeLa) | Human | NPAS4 | 1:3~1:6 | Negative | Online Inquiry |
NPAS4 Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the expression of the NPAS4 gene, which encodes for a neuronal transcription factor integral to synaptic plasticity and memory formation. These unique cell lines serve as vital tools for understanding the molecular underpinnings of neuropsychiatric disorders and synaptic functions. By using CRISPR/Cas9 technology, the knockout of the NPAS4 gene facilitates detailed studies into its role in neural circuitry and behavioral outcomes in various contexts, including stress response and cognitive function.
The key function of NPAS4 Gene Knockout Cell Lines is their ability to provide insights into the repercussions of NPAS4 deficiency on both neuronal development and activity. As NPAS4 is known to regulate the expression of plasticity-related genes, the absence of this transcription factor can illuminate pathways involved in synaptic strengthening and weakening, thereby allowing researchers to dissect fundamental processes relevant to learning and memory. Furthermore, these cell lines can be used in drug discovery efforts aimed at targeting NPAS4-related pathways.
Scientifically, the NPAS4 Gene Knockout Cell Lines hold critical importance in research settings, particularly in neurobiology and pharmacology, where understanding the regulation of synaptic plasticity could lead to novel therapeutic strategies for conditions such as depression, schizophrenia, and other mood disorders. Compared to traditional wild-type cell lines, these knockout models offer researchers a clear view of the consequences of NPAS4 nullification, enabling more precise experimentation.
The distinct advantages of using NPAS4 Gene Knockout Cell Lines include their consistent genetic background, which ensures reproducibility of results, and the model's adaptability for high-throughput screening applications. In an era where precision medicine is becoming increasingly important, these cell lines provide a unique opportunity for targeted research initiatives.
Investing in NPAS4 Gene Knockout Cell Lines equips researchers and clinicians with invaluable tools that can advance our understanding of complex neurobiological phenomena. Our company is at the forefront of delivering high-quality biological products and cell lines that meet rigorous scientific standards, empowering the next wave of breakthroughs in life sciences research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.